Episode 171: Dr. Robert Whitfield & Dr. Tania Dempsey: Mast Cell Activation, and Chronic Inflammation

Why does one patient get a breast implant and feel fine, while another spirals into fatigue, brain fog, joint pain, and a diagnosis no one can explain? The answer may lie in mast cells. In this episode, Dr. Robert Whitfield sits down with Dr. Tania Dempsey — one of the country's leading experts in Mast Cell Activation Syndrome (MCAS) — to explore a connection that most physicians are not trained to recognize: the relationship between implantable devices, chronic immune activation, and conditions like MCAS, POTS, and hypermobility syndrome.

The episode covers what Mast Cell Activation Syndrome actually is and why up to 20% of the population may have it; the top 10 symptoms MCAS patients present with, from fatigue and brain fog to fibromyalgia and food sensitivities; why the MCAS, POTS, and hypermobility triad appears so frequently together; how breast implants interact with the immune system at the tissue level — including new research showing an upregulated plasma cell and B-cell response in certain patients; the role of biofilm, bacterial contamination (Staph epidermidis and Cutibacterium acnes), and oxylipin 10-HOME in driving chronic inflammation; why GLP-1 medications are showing surprising results in MCAS patients; and how mold, glyphosate, organophosphates, and hormonal changes can trigger or worsen MCAS.